Statements (57)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:healthcare_organization
|
gptkbp:bfsLayer |
6
|
gptkbp:bfsParent |
gptkb:Human_herpesvirus_7
|
gptkbp:age |
infants and toddlers
|
gptkbp:associated_with |
immunocompromised individuals
|
gptkbp:bomb_load |
during fever
|
gptkbp:caused_by |
human herpesvirus 6 (HHV-6)
|
gptkbp:characteristics |
rose-pink spots
|
gptkbp:complications |
low
febrile seizures |
gptkbp:difficulty |
generally mild
|
gptkbp:distribution |
worldwide
|
gptkbp:duration |
3 to 5 days
3 to 7 days |
gptkbp:education |
monitor for fever and rash
|
gptkbp:first_described_by |
gptkb:19th_century
|
gptkbp:healthcare |
not a major concern
consult if fever persists seek care for severe symptoms |
https://www.w3.org/2000/01/rdf-schema#label |
Roseola
|
gptkbp:incubation_period |
5 to 15 days
|
gptkbp:is_often_used_in |
gptkb:Person
|
gptkbp:is_protected_by |
good hygiene practices
|
gptkbp:is_tested_for |
PCR test for HHV-6
|
gptkbp:is_vulnerable_to |
no vaccine available
lifelong immunity after infection |
gptkbp:location |
trunk and neck
|
gptkbp:outcome |
full recovery expected
|
gptkbp:premiered_on |
6 months to 2 years
|
gptkbp:related_to |
other herpesviruses
|
gptkbp:risk_factor |
age under 2 years
|
gptkbp:social_responsibility |
gptkb:rubella
gptkb:Kawasaki_disease gptkb:measles clinical evaluation viral exanthems more common in spring and winter |
gptkbp:specialties |
pediatrics
|
gptkbp:status |
not preventable by vaccines
|
gptkbp:symptoms |
cough
sore throat runny nose diarrhea irritability rash swollen lymph nodes high fever conjunctivitis sudden high fever fever and rash rash appears after fever subsides after fever resolution |
gptkbp:transmission |
person-to-person contact
|
gptkbp:treatment |
hydration
symptomatic treatment antipyretics for fever antiviral medications not effective |